These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10874910)

  • 1. [Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?].
    Sissoko D; Ajana F; de la Tribonnière X; Baclet V; Mouton Y
    Presse Med; 2000 May 27-Jun 3; 29(19):1041-2. PubMed ID: 10874910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy.
    Bourezane Y; Salard D; Hoen B; Vandel S; Drobacheff C; Laurent R
    Clin Infect Dis; 1998 Nov; 27(5):1321-2. PubMed ID: 9827291
    [No Abstract]   [Full Text] [Related]  

  • 3. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
    Santos RP; Ramilo O; Barton T
    Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.
    Lanzafame M; Rovere P; De Checchi G; Trevenzoli M; Turazzini M; Parrinello A
    Scand J Infect Dis; 2001; 33(6):475-6. PubMed ID: 11450872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
    Soriano V; Dona C; Barreiro P; González-Lahoz J
    AIDS; 2000 Jul; 14(11):1672-3. PubMed ID: 10983663
    [No Abstract]   [Full Text] [Related]  

  • 6. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG).
    Fields KS; Petersen MJ; Chiao E; Tristani-Firouzi P
    J Drugs Dermatol; 2005; 4(4):510-3. PubMed ID: 16004028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DRESS syndrome associated with nevirapine therapy.
    Claudio GA; Martin AF; de Dios Perrino S; Velasco AA
    Arch Intern Med; 2001 Nov; 161(20):2501-2. PubMed ID: 11700164
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus.
    Knudtson E; Para M; Boswell H; Fan-Havard P
    Obstet Gynecol; 2003 May; 101(5 Pt 2):1094-7. PubMed ID: 12738113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill.
    Daniel OJ; Krain AB; Ogun SA; Odusoga OL; Boyle BA
    J Natl Med Assoc; 2005 Dec; 97(12):1719-21. PubMed ID: 16396066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone.
    Natkunarajah J; Goolamali S; Craythorne E; Benton E; Smith C; Morris-Jones R; Wendon J; Higgins E; Creamer D
    Eur J Dermatol; 2011; 21(3):385-91. PubMed ID: 21527371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine-induced hepatitis treated with corticosteroids?
    Leitze Z; Nadeem A; Choudhary A; Saul Z; Roberts I; Manthous CA
    AIDS; 1998 Jun; 12(9):1115-7. PubMed ID: 9662216
    [No Abstract]   [Full Text] [Related]  

  • 12. Sex differences in nevirapine rash.
    Bersoff-Matcha SJ; Miller WC; Aberg JA; van Der Horst C; Hamrick HJ; Powderly WG; Mundy LM
    Clin Infect Dis; 2001 Jan; 32(1):124-9. PubMed ID: 11118391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS).
    Gill S; Sagar A; Shankar S; Nair V
    Indian J Pharmacol; 2013; 45(4):401-2. PubMed ID: 24014920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
    Oelze LL; Pillow MT
    J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update.
    Tas S; Simonart T
    Dermatology; 2003; 206(4):353-6. PubMed ID: 12771485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug rash with eosinophilia and systemic symptoms due to telaprevir.
    Montaudié H; Passeron T; Cardot-Leccia N; Sebbag N; Lacour JP
    Dermatology; 2010; 221(4):303-5. PubMed ID: 20798484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).
    Tas S; Simonart T
    Acta Clin Belg; 1999 Aug; 54(4):197-200. PubMed ID: 10544509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphasalazine-induced DRESS.
    Teo L; Tan E
    Singapore Med J; 2006 Mar; 47(3):237-9. PubMed ID: 16518561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms.
    Wongkitisophon P; Chanprapaph K; Rattanakaemakorn P; Vachiramon V
    Acta Derm Venereol; 2012 Mar; 92(2):200-5. PubMed ID: 22002792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review.
    Ganeva M; Gancheva T; Lazarova R; Troeva J; Baldaranov I; Vassilev I; Hristakieva E; Tzaneva V
    Int J Dermatol; 2008 Aug; 47(8):853-60. PubMed ID: 18717872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.